3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Hypoxia
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Melanoma
1
Gastrointestinal Stromal Tumors
1
Interventions
Melphalan
2
Carboplatin
2
sodium thiosulfate
1
Verteporfin
1
Thiotepa
1
TH 302
1
Surveys and Questionnaires
1
Mannitol
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neuroectodermal Tumors, Primitive
×
TH 302
×
Clear all
NCT01381822
2014-04-21
TH-CR-410
Threshold Pharmaceuticals
Phase 1
Unknown
58 enrolled